Navigation Links
Global bid to bring world's leading cancer minds to Manchester, UK
Date:7/10/2013

A global recruitment drive to bring 20 of the world's best cancer experts and their teams to Manchester, in the United Kingdom, is now underway.

Specialist cancer centre The Christie NHS Foundation Trust and The University of Manchester are jointly funding the 30 million plan as part of their role in the Manchester Cancer Research Centre (MCRC).

The recruitment bid will bring 20 top-flight academics and their teams of experts to the city. In total it will attract 100 new staff with clinical, research and teaching expertise in screening and prevention; lung cancer; radiotherapy; haematological oncology; women's cancer; melanoma and personalised cancer therapy.

Around 13 of the academic posts and their associated teams will have a clinical base within The Christie as well as a university role. The remaining science roles will be based within the MCRC - a unique collaboration between The Christie, The University of Manchester and Cancer Research UK (CR-UK). The majority of these posts will be based in a custom-built facility due to open in 2014, opposite The Christie in south Manchester. The flagship building has been designed to bring research into cancer biology, drug discovery and clinical trials together. Some posts will also be based in the neighbouring CR-UK Paterson Institute for Cancer Research, part of The University of Manchester.

All new posts are also part of a series of large-scale initiatives in health care and health science being driven by the Manchester Academic Health Science Centre (MAHSC) which is a partnership of six of Greater Manchester's NHS Trusts, including The Christie, and The University of Manchester. The partnership prioritises key areas of health within Greater Manchester, one of which is cancer. The package of support will fund cancer leaders and their teams for five years as well as providing some laboratory set-up costs and materials to enable the teams to carry out experiments.

Caroline Shaw, Chief Executive of The Christie, said: "This is a major coup for Manchester. It means that our patients will have the chance to be the very first people to participate in global trials and have access to the very latest cancer treatments.

"The new staff will play a huge part in teaching and inspiring the next generation of cancer doctors as they form a solid bridge between academic and practical training."

Professor Ian Jacobs, Dean of the Faculty of Medical and Human Sciences, Vice President of The University of Manchester and also MAHSC Director, said: "An investment on this scale is hugely significant by world standards and a first for cancer research in Manchester. It will enable us to add to our already excellent team by recruiting some of the brightest international research talent in cancer to the city.

"It has come about because of the investment of The Christie charity and The University of Manchester and reflects our ambition to be a world leader in both research and patient care.

"The new posts will provide a step change in the way researchers and clinicians combine forces to tackle cancer."

Professor Richard Marais, Director of Cancer Research UK's Paterson Institute based at The University of Manchester, said: "We hope to begin advertising for these posts, including four group leaders funded by CR-UK, in the Autumn. This is an exciting time for science and the search for treatments and Manchester continues to playing a key role in this work."

Professor Nic Jones, Director of the MCRC, said: "This big cash-injection will add to the high-calibre scientists who form part of the Manchester Cancer Research Centre many of whom will be based at our new flagship building due to open in summer 2014. It will bring even more researchers and specialists together in Manchester widening even further our range of expertise and helping to revolutionise cancer treatment and translate research into treatments which can benefit patients."


'/>"/>

Contact: Alison Barbuti
alison.barbuti@manchester.ac.uk
44-016-127-58383
University of Manchester
Source:Eurekalert

Related medicine news :

1. Global Big Data Market – Size, Share, Forecast, Segments, Opportunity, Report 2012 – 2018
2. Humidity Changes Cause Global Health and Dehydration Crisis Warns Water Researcher Sharon Kleyne
3. Sydneys urban areas to be hit hardest by global warming
4. Synthetic Biology Market is Expected to Reach USD 16.7 Billion Globally in 2018 - Transparency Market Research
5. Sallie Fraenkel Named Executive Vice President of the Global Spa & Wellness Summit
6. Global Pioneers in Patient Advocacy, Regulation and Research to Speak at DIA Meeting
7. Professional and Social Success Characterized the 2nd Global Conference by Dental Implants Leader MIS Implants Technologies Ltd.
8. David Icke to Launch Global TV and Radio Station Called The People's Voice
9. Research Suggests That Unhealthy Food Addiction Could Explain Global Obesity Epidemic
10. Global Youth Summit on The Future of Medicine-Shreya Rangarajan selected to represent Roland Park Country School and The State of Maryland
11. GHIT Fund celebrates historic beginning of Japanese R&D initiative in global health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... ... February 17, 2017 , ... For ... assistance management solution to the exhibit floor for the 2017 HIMSS Conference ... , From Feb. 19–23, 2017, more than 40,000 healthcare industry professionals are expected ...
(Date:2/17/2017)... Seattle, WA (PRWEB) , ... February 17, 2017 ... ... health management organizations, has been named a finalist in the 8th Annual DecisionHealth ... impacting America's healthcare delivery system. Qualis Health’s work is recognized across multiple award ...
(Date:2/17/2017)... ... 2017 , ... Pharmica Consulting attended CHI's 8th Annual SCOPE ... trial planning and management. Pharmica discussed the importance of effective project management, data ... by Pharmica’s booth were able to demo its cloud-based Resource Management Tool, ...
(Date:2/17/2017)... ... February 17, 2017 , ... Top neuroendocrine cancer doctors, nurses and specialists from ... February 21 - 23 in Beaver Creek, CO. It was announced today by Cindy ... year in Beaver Creek, hosting over 60 faculty members and addressing unmet needs of ...
(Date:2/16/2017)... ... 17, 2017 , ... For some cancer survivors, the memories ... Physician researchers at The Marcus Institute of Integrative Health at Thomas Jefferson ... reducing symptoms of traumatic stress in cancer patients and published their results ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... 17, 2017  Noble Capital Markets announced today that ... (Nasdaq: EPIX ). The report was issued ... , PhD. ESSA Pharmaceuticals is a clinical ... cancer (CRPC). Its lead compound EPI-506, is a small ... of the androgen receptor, thereby has potential to overcome ...
(Date:2/16/2017)... Quest Diagnostics (NYSE: DGX ), ... announced that it has been named one of the ... The annual survey designated Quest Diagnostics as ... Pharmacy and Other Services" industry to attain Most Admired ... attain the designation. This is the second consecutive year ...
(Date:2/16/2017)... Feb. 16, 2017  Aralez Pharmaceuticals Inc. (NASDAQ: ... company, today announced that executive management will participate in ... held February 22-23, 2017. Adrian Adams , Chief ... at 1:35 p.m. local time on Wednesday, February 22, ... for the event may be accessed from the Investors ...
Breaking Medicine Technology: